Paying for personalized care: Cancer biomarkers and comparative effectiveness
- Published in:
- Molecular Oncology, 2012, v. 6, n. 2, p. 260, doi. 10.1016/j.molonc.2012.02.006
- By:
- Publication type:
- Article
Works matching IS 15747891 AND DT 2012 AND VI 6 AND IP 2
Results: 17
1
2
Germline pharmacogenomics in oncology: Decoding the patient for targeting therapy
- Published in:
- Molecular Oncology, 2012, v. 6, n. 2, p. 251, doi. 10.1016/j.molonc.2012.01.005
- By:
- Publication type:
- Article
3
Cancer immunotherapy
- Published in:
- Molecular Oncology, 2012, v. 6, n. 2, p. 242, doi. 10.1016/j.molonc.2012.01.002
- By:
- Publication type:
- Article
4
Hematopoietic growth factors: Personalization of risks and benefits
- Published in:
- Molecular Oncology, 2012, v. 6, n. 2, p. 237, doi. 10.1016/j.molonc.2012.03.001
- By:
- Publication type:
- Article
5
Hormonal therapy in breast cancer: A model disease for the personalization of cancer care
- Published in:
- Molecular Oncology, 2012, v. 6, n. 2, p. 222, doi. 10.1016/j.molonc.2012.02.003
- By:
- Publication type:
- Article
6
Individualization of cancer treatment from radiotherapy perspective
- Published in:
- Molecular Oncology, 2012, v. 6, n. 2, p. 211, doi. 10.1016/j.molonc.2012.01.007
- By:
- Publication type:
- Article
7
The challenge to bring personalized cancer medicine from clinical trials into routine clinical practice: The case of the Institut Gustave Roussy
- Published in:
- Molecular Oncology, 2012, v. 6, n. 2, p. 204, doi. 10.1016/j.molonc.2012.02.008
- By:
- Publication type:
- Article
8
Moving molecular targeted drug therapy towards personalized medicine: Issues related to clinical trial design
- Published in:
- Molecular Oncology, 2012, v. 6, n. 2, p. 196, doi. 10.1016/j.molonc.2012.01.009
- By:
- Publication type:
- Article
9
Molecular imaging for personalized cancer care
- Published in:
- Molecular Oncology, 2012, v. 6, n. 2, p. 182, doi. 10.1016/j.molonc.2012.02.005
- By:
- Publication type:
- Article
10
Molecular pathology
- Published in:
- Molecular Oncology, 2012, v. 6, n. 2, p. 177, doi. 10.1016/j.molonc.2012.02.007
- By:
- Publication type:
- Article
11
Discovery of small molecule cancer drugs: Successes, challenges and opportunities
- Published in:
- Molecular Oncology, 2012, v. 6, n. 2, p. 155, doi. 10.1016/j.molonc.2012.02.004
- By:
- Publication type:
- Article
12
Bioinformatics and systems biology
- Published in:
- Molecular Oncology, 2012, v. 6, n. 2, p. 147, doi. 10.1016/j.molonc.2012.01.008
- By:
- Publication type:
- Article
13
Cancer biomarkers
- Published in:
- Molecular Oncology, 2012, v. 6, n. 2, p. 140, doi. 10.1016/j.molonc.2012.01.010
- By:
- Publication type:
- Article
14
Omics and therapy – A basis for precision medicine
- Published in:
- Molecular Oncology, 2012, v. 6, n. 2, p. 128, doi. 10.1016/j.molonc.2012.02.009
- By:
- Publication type:
- Article
15
The biology of personalized cancer medicine: Facing individual complexities underlying hallmark capabilities
- Published in:
- Molecular Oncology, 2012, v. 6, n. 2, p. 111, doi. 10.1016/j.molonc.2012.01.011
- By:
- Publication type:
- Article
16
Personalized cancer medicine – A strategy to counteract an increasing cancer challenge
- Published in:
- 2012
- By:
- Publication type:
- Editorial
17
Editorial Board
- Published in:
- Molecular Oncology, 2012, v. 6, n. 2, p. ii, doi. 10.1016/S1574-7891(12)00032-4
- Publication type:
- Article